FR1455065A - Procédé d'enrobage et compositions de pellicule d'enrobage - Google Patents
Procédé d'enrobage et compositions de pellicule d'enrobageInfo
- Publication number
- FR1455065A FR1455065A FR7501A FR7501A FR1455065A FR 1455065 A FR1455065 A FR 1455065A FR 7501 A FR7501 A FR 7501A FR 7501 A FR7501 A FR 7501A FR 1455065 A FR1455065 A FR 1455065A
- Authority
- FR
- France
- Prior art keywords
- cores
- coating
- methylcellulose
- hydrochloride
- solvent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 238000000576 coating method Methods 0.000 title abstract 4
- 239000011248 coating agent Substances 0.000 title abstract 3
- 239000000203 mixture Substances 0.000 title abstract 2
- 239000002904 solvent Substances 0.000 abstract 5
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 abstract 4
- 239000004615 ingredient Substances 0.000 abstract 4
- 238000001704 evaporation Methods 0.000 abstract 3
- 239000007888 film coating Substances 0.000 abstract 3
- 238000009501 film coating Methods 0.000 abstract 3
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 abstract 3
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 abstract 3
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 abstract 3
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 abstract 3
- 229920000609 methyl cellulose Polymers 0.000 abstract 3
- 239000001923 methylcellulose Substances 0.000 abstract 3
- FLKPEMZONWLCSK-UHFFFAOYSA-N phthalic acid di-n-ethyl ester Natural products CCOC(=O)C1=CC=CC=C1C(=O)OCC FLKPEMZONWLCSK-UHFFFAOYSA-N 0.000 abstract 3
- 238000005507 spraying Methods 0.000 abstract 3
- PYHRZPFZZDCOPH-QXGOIDDHSA-N (S)-amphetamine sulfate Chemical compound [H+].[H+].[O-]S([O-])(=O)=O.C[C@H](N)CC1=CC=CC=C1.C[C@H](N)CC1=CC=CC=C1 PYHRZPFZZDCOPH-QXGOIDDHSA-N 0.000 abstract 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 abstract 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract 2
- 229960000836 amitriptyline Drugs 0.000 abstract 2
- KRMDCWKBEZIMAB-UHFFFAOYSA-N amitriptyline Chemical compound C1CC2=CC=CC=C2C(=CCCN(C)C)C2=CC=CC=C21 KRMDCWKBEZIMAB-UHFFFAOYSA-N 0.000 abstract 2
- 239000003795 chemical substances by application Substances 0.000 abstract 2
- 238000004040 coloring Methods 0.000 abstract 2
- 238000005096 rolling process Methods 0.000 abstract 2
- 239000000454 talc Substances 0.000 abstract 2
- 229910052623 talc Inorganic materials 0.000 abstract 2
- BFPYWIDHMRZLRN-UHFFFAOYSA-N 17alpha-ethynyl estradiol Natural products OC1=CC=C2C3CCC(C)(C(CC4)(O)C#C)C4C3CCC2=C1 BFPYWIDHMRZLRN-UHFFFAOYSA-N 0.000 abstract 1
- JZUFKLXOESDKRF-UHFFFAOYSA-N Chlorothiazide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC2=C1NCNS2(=O)=O JZUFKLXOESDKRF-UHFFFAOYSA-N 0.000 abstract 1
- BFPYWIDHMRZLRN-SLHNCBLASA-N Ethinyl estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 BFPYWIDHMRZLRN-SLHNCBLASA-N 0.000 abstract 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 abstract 1
- SHAYBENGXDALFF-UHFFFAOYSA-N Nortriptyline hydrochloride Chemical compound [Cl-].C1CC2=CC=CC=C2C(=CCC[NH2+]C)C2=CC=CC=C21 SHAYBENGXDALFF-UHFFFAOYSA-N 0.000 abstract 1
- RGCVKNLCSQQDEP-UHFFFAOYSA-N Perphenazine Chemical compound C1CN(CCO)CCN1CCCN1C2=CC(Cl)=CC=C2SC2=CC=CC=C21 RGCVKNLCSQQDEP-UHFFFAOYSA-N 0.000 abstract 1
- 229940083181 centrally acting adntiadrenergic agent methyldopa Drugs 0.000 abstract 1
- 229960002568 ethinylestradiol Drugs 0.000 abstract 1
- 229960002003 hydrochlorothiazide Drugs 0.000 abstract 1
- 229960002102 imipramine hydrochloride Drugs 0.000 abstract 1
- XZZXIYZZBJDEEP-UHFFFAOYSA-N imipramine hydrochloride Chemical compound [Cl-].C1CC2=CC=CC=C2N(CCC[NH+](C)C)C2=CC=CC=C21 XZZXIYZZBJDEEP-UHFFFAOYSA-N 0.000 abstract 1
- CGIGDMFJXJATDK-UHFFFAOYSA-N indomethacin Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 CGIGDMFJXJATDK-UHFFFAOYSA-N 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- LZCOQTDXKCNBEE-IKIFYQGPSA-N methscopolamine Chemical compound C1([C@@H](CO)C(=O)O[C@H]2C[C@@H]3[N+]([C@H](C2)[C@@H]2[C@H]3O2)(C)C)=CC=CC=C1 LZCOQTDXKCNBEE-IKIFYQGPSA-N 0.000 abstract 1
- 229960001383 methylscopolamine Drugs 0.000 abstract 1
- 229960000762 perphenazine Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
Landscapes
- Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Preparation (AREA)
- Linear Motors (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US360772A US3383236A (en) | 1964-04-17 | 1964-04-17 | Continuous pharmaceutical film coating process |
Publications (1)
Publication Number | Publication Date |
---|---|
FR1455065A true FR1455065A (fr) | 1966-10-14 |
Family
ID=23419346
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR7501A Expired FR1455065A (fr) | 1964-04-17 | 1965-03-01 | Procédé d'enrobage et compositions de pellicule d'enrobage |
Country Status (11)
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3524756A (en) * | 1967-05-29 | 1970-08-18 | Colorcon | Process of coating tablets with alternate tacky and non-tacky layers |
US3486951A (en) * | 1967-06-16 | 1969-12-30 | Corning Glass Works | Method of manufacturing semiconductor devices |
US3539380A (en) * | 1968-01-08 | 1970-11-10 | Upjohn Co | Methylcellulose and polyalkylene glycol coating of solid medicinal dosage forms |
US3900583A (en) * | 1971-08-10 | 1975-08-19 | American Home Prod | Contoured belt coating method |
US3919436A (en) * | 1971-09-27 | 1975-11-11 | Eisai Co Ltd | Process for preparation of coated medicines |
JPS50129727A (enrdf_load_stackoverflow) * | 1974-04-04 | 1975-10-14 | ||
US4140756A (en) * | 1976-06-10 | 1979-02-20 | Mead Johnson & Company | Film-coated matrix core tablet |
US4173626A (en) | 1978-12-11 | 1979-11-06 | Merck & Co., Inc. | Sustained release indomethacin |
JPS5620513A (en) * | 1979-07-31 | 1981-02-26 | Eisai Co Ltd | Sugar-coated tablet containing fat-soluble drug |
US4302440B1 (en) * | 1980-07-31 | 1986-08-05 | Easily-swallowed, powder-free and gastric-disintegrable aspirin tablet thinly-coated with hydroxypropyl methylcellulose and aqueous spray-coating preparation thereof | |
US4508702A (en) * | 1982-06-14 | 1985-04-02 | Key Pharmaceuticals, Inc. | Sustained release aspirin |
DE3236192A1 (de) | 1982-09-30 | 1984-04-05 | Dr. Karl Thomae Gmbh, 7950 Biberach | Gesteuertes und geregeltes verfahren zum vollautomatischen, kontinuierlichen dragieren |
US4555399A (en) * | 1983-11-18 | 1985-11-26 | Key Pharmaceuticals, Inc. | Aspirin tablet |
GB8524001D0 (en) * | 1985-09-30 | 1985-11-06 | Glaxo Group Ltd | Pharmaceutical composition |
US4795032A (en) * | 1987-12-04 | 1989-01-03 | S. C. Johnson & Son, Inc. | Wash-added, rinse-activated fabric conditioner and package |
US4970008A (en) * | 1988-12-20 | 1990-11-13 | Kandathil Thomas V | Fabric conditioner comprising a mixture of quaternary ammonium compounds and select tertiary amines |
CA2011684C (en) * | 1989-07-31 | 2000-05-02 | Lawrence J. Daher | Aqueous film coating |
CA2349700A1 (en) | 1998-11-12 | 2000-05-18 | Merck & Co., Inc. | Therapeutic polymorphs of a gaba-a alpha-5 inverse agonist and pamoate formulations of the same |
US20020054903A1 (en) * | 1999-10-19 | 2002-05-09 | Joseph Tyler | Direct compression polymer tablet core |
US6733780B1 (en) | 1999-10-19 | 2004-05-11 | Genzyme Corporation | Direct compression polymer tablet core |
US20060177415A1 (en) * | 2004-11-01 | 2006-08-10 | Burke Steven K | Once a day formulation for phosphate binders |
US7985418B2 (en) | 2004-11-01 | 2011-07-26 | Genzyme Corporation | Aliphatic amine polymer salts for tableting |
WO2007027566A2 (en) * | 2005-09-02 | 2007-03-08 | Genzyme Corporation | Method for removing phosphate and polymer used therefore |
EP3000460A1 (en) | 2005-09-15 | 2016-03-30 | Genzyme Corporation | Sachet formulation for amine polymers |
JP2009536246A (ja) * | 2006-05-05 | 2009-10-08 | ゲンズイメ コーポレーション | ホスフェート捕捉剤としてのアミン縮合重合体 |
BRPI0715053A2 (pt) * | 2006-07-18 | 2013-03-19 | Genzyme Corp | composiÇço farmacÊutica, mÉtodo para tratar doenÇas, e, polÍmero |
US8425887B2 (en) | 2006-09-29 | 2013-04-23 | Genzyme Corporation | Amide dendrimer compositions |
JP2010513271A (ja) * | 2006-12-14 | 2010-04-30 | ゲンズイメ コーポレーション | アミド−アミンポリマー組成物 |
US20100129309A1 (en) * | 2007-02-23 | 2010-05-27 | Dhal Pradeep K | Amine polymer compositions |
JP2010520285A (ja) * | 2007-03-08 | 2010-06-10 | ゲンズイメ コーポレーション | スルホンポリマー組成物 |
WO2008133954A1 (en) * | 2007-04-27 | 2008-11-06 | Genzyme Corporation | Amido-amine dendrimer compositions |
EP2217215A1 (en) * | 2007-12-14 | 2010-08-18 | Genzyme Corporation | Coated pharmaceutical compositions |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA652743A (en) * | 1962-11-20 | Charles E. Frosst And Co. | Film coating for tablets | |
GB978264A (enrdf_load_stackoverflow) * | 1960-02-26 | |||
NL282752A (enrdf_load_stackoverflow) * | 1961-09-10 | |||
US3256111A (en) * | 1964-12-04 | 1966-06-14 | Abbott Lab | Method for coating tablets |
-
1964
- 1964-04-17 US US360772A patent/US3383236A/en not_active Expired - Lifetime
-
1965
- 1965-01-14 IL IL22778A patent/IL22778A/xx unknown
- 1965-01-26 BR BR166503/65A patent/BR6566503D0/pt unknown
- 1965-01-28 DE DE19651492029 patent/DE1492029A1/de active Pending
- 1965-02-08 GB GB5354/65A patent/GB1059508A/en not_active Expired
- 1965-02-22 NL NL6502190A patent/NL6502190A/xx unknown
- 1965-03-01 FR FR7501A patent/FR1455065A/fr not_active Expired
- 1965-03-24 BE BE661581D patent/BE661581A/xx unknown
- 1965-04-13 NO NO157671A patent/NO117494B/no unknown
- 1965-04-14 SE SE04965/65A patent/SE352531B/xx unknown
- 1965-04-15 ES ES0312253A patent/ES312253A1/es not_active Expired
Also Published As
Publication number | Publication date |
---|---|
BR6566503D0 (pt) | 1973-07-17 |
US3383236A (en) | 1968-05-14 |
ES312253A1 (es) | 1966-02-16 |
GB1059508A (en) | 1967-02-22 |
NO117494B (enrdf_load_stackoverflow) | 1969-08-18 |
SE352531B (enrdf_load_stackoverflow) | 1973-01-08 |
BE661581A (enrdf_load_stackoverflow) | 1965-09-24 |
IL22778A (en) | 1968-08-22 |
NL6502190A (enrdf_load_stackoverflow) | 1965-10-18 |
DE1492029A1 (de) | 1969-02-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FR1455065A (fr) | Procédé d'enrobage et compositions de pellicule d'enrobage | |
US3097144A (en) | Heat-cured, polymeric, medicinal dosage film coatings containing a polyvinylpyrrolidone copolymer, polyethenoid acid, and polyethylene glycol | |
BR0317481A (pt) | Processo para a produção de produtos farmacêuticos revestidos e de suplementos alimentìcios com gradientes de concentração no revestimento | |
US4880636A (en) | Film coated tablet of ranitidine HCl | |
US3390049A (en) | Pharmaceutical tablets coated with wax-free ammonia solubilized water soluble shellac | |
AR215113A1 (es) | Nuevos pesticidas derivados de esteres bencilicos del acido 3,3-dimetil-ciclopropano-carboxilico,procedimiento de preparacion y composicion pesticida | |
KR20080027783A (ko) | 난용성 활성 성분을 함유하는 정제 | |
GB1283054A (en) | Improvements in and relating to delayed release veterinary and pharmaceutical compositions | |
IL55556A (en) | 3-(2-hydroxy-4-(substituted)phenyl)-cycloalkanone and cycloalkanol derivatives and unsaturated analogues thereof,their preparation and pharmaceutical compositions containing them | |
US2214476A (en) | Method of making mirrors | |
US3149039A (en) | Thin film coating for tablets and the like and method of coating | |
US2363354A (en) | Method of making mirrors | |
GB1385285A (en) | Pharmaceutical capsule wall materials | |
US3379554A (en) | Spray coating of pharmaceutical cores with a carboxylvinyl polymer and polyethylene glycol | |
AT297719B (de) | Verfahren zur herstellung von neuen pyrazol <3,4-e> <1,4>-diazepin-7 (1h)-onverbindungen sowie von deren salzen | |
US3696188A (en) | Laminated tablets | |
NL190371B (nl) | Cycloalkanonoximethers met therapeutische eigenschappen en zuuradditiezouten en quaternaire ammoniumderivaten daarvan, alsmede farmaceutische samenstellingen, die deze verbindingen bevatten, en werkwijze voor de bereiding van de verbindingen. | |
US3132074A (en) | Process of coating pharmaceutical forms and product thereof | |
US3398225A (en) | Coated 2, 2-dichlorovinyl phosphate and polyvinyl chloride resin anthelmintic compositions | |
JPS5228926A (en) | Process for film coating of medicines | |
DE69104836T2 (de) | Mit gelatine überzogene arzneimittel sowie verfahren zu deren herstellung. | |
NL159393B (nl) | Werkwijze voor het bereiden van een geneesmiddel tegen ontstekingen, dat een 9,21-dihalogeen-11-geoxygeneerd-17-alfa-hydroxy-3,20-diketo-1,4-pregnadieen of -pregneen als actief bestanddeel bevat, alsmede het aldus verkregen gevormde geneesmiddel en een werkwijze voor het bereiden van verbindingen geschikt voor gebruik bij de bereiding van een zodanig geneesmiddel. | |
US3149041A (en) | Thin film coating for tablets and the like and method of coating | |
GB908282A (en) | Coated pharmaceutical granules and tablets thereof | |
US3149038A (en) | Thin film coating for tablets and the like and method of coating |